Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial

Affiliations

• ¹ Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700 Thailand; Siriraj Institute of Clinical Research (SICRES), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
• ² Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria 3052 Australia; Department of Pediatrics, The University of Melbourne, Parkville, Victoria 3010 Australia.
• ³ Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700 Thailand.
• ⁴ National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science Development Agency (NSTDA), Pathum Thani 12120 Thailand.
• ⁵ Mahidol University International College, Mahidol University, Salaya, Nakhon Pathom 73170 Thailand.
• ⁶ Siriraj Institute of Clinical Research (SICRES), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand; Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700 Thailand. Electronic address: kulkanya.cho@mahidol.ac.th.